Polystyrene particles induces asthma-like Th2-mediated lung injury through IL-33 secretion

Area of Science:

• Environmental Science
• Toxicology
• Immunology

Background:

• Polystyrene (PS) microplastics from packaging pollution pose environmental risks.
• Airborne microplastic inhalation is a growing concern for human respiratory health.

Purpose of the Study:

• To investigate the pulmonary toxic effects of polystyrene (PS) microplastics via inhalation.
• To elucidate the mechanisms of airway inflammation and immune response induced by PS microplastics.

Main Methods:

• Nose-only inhalation exposure of mice to PS microplastics (50 nm to 1 μm).
• Assessment of asthma-like symptoms, airway inflammation, and Th2 immune responses.
• Spatial transcriptome analysis to identify cellular pathways involved in lung injury.
• In vitro experiments stimulating epithelial cells and analyzing splenocyte responses.
• Treatment with an IL-33 inhibitor and dexamethasone to evaluate therapeutic potential.

Main Results:

• PS microplastic inhalation induced significant asthma-like symptoms, including airway inflammation and hyperresponsiveness.
• Smaller PS particle sizes correlated with more severe pulmonary inflammatory responses.
• Epithelial cells were identified as key drivers of the IL-33 signaling pathway and Th2 cell activation in PS-induced lung injury.
• PS exposure enhanced Th2 immune responses, evidenced by increased cytokine levels and mRNA expression.
• IL-33 inhibition and dexamethasone treatment effectively mitigated PS-induced Th2-mediated lung inflammation.

Conclusions:

• Polystyrene microplastic inhalation poses a significant risk to respiratory health, inducing asthma-like conditions.
• The IL-33 signaling pathway, driven by epithelial cells, plays a crucial role in PS-induced lung inflammation and Th2 immune responses.
• Targeting the IL-33 pathway or using anti-inflammatory agents like dexamethasone shows promise for managing microplastic-induced respiratory damage.